You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

FOLFIRI

Showing 1 - 25 of 523
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Metastatic Colorectal Cancer, CRC, KRAS/NRAS Mutation Trial (Onvansertib, FOLFIRI, Bevacizumab)

Not yet recruiting
  • Metastatic Colorectal Cancer
  • +2 more
  • (no location specified)
Oct 24, 2023

Colorectal Cancer, Metastatic Colon Cancer Trial (Ompenaclid (RGX-202-01) + FOLFIRI + Bevacizumab, Placebo + FOLFIRI +

Not yet recruiting
  • Colorectal Cancer
  • Metastatic Colon Cancer
  • Ompenaclid (RGX-202-01) + FOLFIRI + Bevacizumab
  • Placebo + FOLFIRI + Bevacizumab
  • (no location specified)
Aug 1, 2023

Colorectal Cancer Trial in Shanghai (Fruquintinib+mFOLFOX6/FOLFIRI)

Recruiting
  • Colorectal Cancer
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Aug 23, 2023

Colorectal Cancer Trial in Shanghai (FOLFIRI+Bevacizumab)

Recruiting
  • Colorectal Cancer
  • Shanghai, Pudong, China
    Affiliated Cancer Hospital of Fudan University
Jul 24, 2023

Unresectable or Metastatic Colorectal Cancer Trial in Shenyang (FOLFOX/FOLFIRI)

Recruiting
  • Unresectable or Metastatic Colorectal Cancer
  • Shenyang, Liaoning, China
    Liaoning Cancer Hospital & Institute
Mar 22, 2023

Colorectal Cancer Trial in Hangzhou (Ametumumab, Anti-PD-1 mAb, Cetuximab)

Not yet recruiting
  • Colorectal Cancer
  • Hangzhou, Zhejiang, China
    Sir Run Run Shaw Hospital, Zhejiang University School of Medicin
Jan 30, 2023

Colorectal Cancer Trial in Changsha (fruquintinib and FOLFIRI)

Not yet recruiting
  • Colorectal Cancer
  • fruquintinib and FOLFIRI
  • Changsha, Hunan, China
    Hunan Cancer hospital
Apr 24, 2023

Unresectable Colon Cancer Peritoneal Metastases, PMMR/Ras/BRAF Wild-type Trial in Huzhou (Serplulimab Combined With FOLFIRI and

Recruiting
  • Unresectable Colon Cancer Peritoneal Metastases
  • PMMR/Ras/BRAF Wild-type
  • Serplulimab Combined With FOLFIRI and Bevacizumab
  • Huzhou, Zhejiang, China
    Changxing County People's Hospital
Feb 14, 2023

Metastatic Colorectal Cancer Trial in ShangHai (Fruquintinib)

Not yet recruiting
  • Metastatic Colorectal Cancer
  • ShangHai, Shanghai, China
    Fudan University Cancer Hospital
Jul 3, 2022

Metastatic Colorectal Cancer Trial in Wuhan (Fruquintinib Combined With mFOLFOX6/FOLFIRI)

Recruiting
  • Metastatic Colorectal Cancer
  • Fruquintinib Combined With mFOLFOX6/FOLFIRI
  • Wuhan, Hubei, China
    Zhongnan Hopital of Wuhan University
Oct 25, 2022

Colorectal Cancer, Colorectal Adenocarcinoma, Colo-rectal Cancer Trial (DKN-01, FOLFIRI, Bevacizumab)

Not yet recruiting
  • Colorectal Cancer
  • +3 more
  • (no location specified)
Jul 28, 2022

Metastatic Colorectal Cancer Trial in Madrid (Aflibercept, Irinotecan, folinic acid (dl racemic))

Active, not recruiting
  • Metastatic Colorectal Cancer
  • Madrid, Spain
    Spanish Cooperative Group for Digestive Tumour Therapy (TTD)
Oct 10, 2022

Metastatic Colorectal Cancer Trial in Shanghai (Fruquintinib, FOLFIRI, mFOLFOX6)

Not yet recruiting
  • Metastatic Colorectal Cancer
  • Shanghai, Shanghai, China
    Department of Colorectal Surgery Fudan University Shanghai Caner
Nov 23, 2022

Metastatic Colorectal Cancer Trial (Cetuximab + Envafolimab + mFOLFOXIRI, Cetuximab + mFOLFOX6/FOLFIRI)

Not yet recruiting
  • Metastatic Colorectal Cancer
  • Cetuximab + Envafolimab + mFOLFOXIRI
  • Cetuximab + mFOLFOX6/FOLFIRI
  • (no location specified)
Jul 24, 2023

Colorectal Cancer Trial (Avastin/FOLFIRI, Curcumin)

Completed
  • Colorectal Cancer
  • (no location specified)
Mar 28, 2022

Metastatic Colorectal Cancer Trial in Beijing, Tianjin (CMAB009, Irinotecan, Folinic acid)

Active, not recruiting
  • Metastatic Colorectal Cancer
  • Beijing, Beijing, China
  • +1 more
Oct 18, 2022

Metastatic Colorectal Cancer Trial in Hangzhou (FOLFIRI)

Recruiting
  • Metastatic Colorectal Cancer
  • FOLFIRI
  • Hangzhou, Zhejinag, China
    SAHZU
Apr 30, 2022

New Prognostic Score for Adult RAS Wild-type mCRC Treated With

Active, not recruiting
  • Metastatic Colorectal Cancer
  • RAS Wild-type
  • Freiburg, Baden-Württemberg, Germany
    Praxis für interdisziplinäre Onkologie & Hämatologie
Jul 29, 2022

Advanced Solid Tumor Trial in New York, Houston, Salt Lake City (RP-6306 (oral PKMYT1 inhibitor))

Recruiting
  • Advanced Solid Tumor
  • RP-6306 (oral PKMYT1 inhibitor)
  • New York, New York
  • +2 more
Jun 21, 2022

Metastatic Microsatellite-stable Colorectal Cancer Trial in China (Experimental drug, Control Rx)

Recruiting
  • Metastatic Microsatellite-stable Colorectal Cancer
  • Experimental drug
  • Control Rx
  • Hefei, Anhui, China
  • +11 more
Mar 13, 2023

Colorectal Cancer Trial in Madrid (FOLFOX regimen, Panitumumab, Bevacizumab)

Recruiting
  • Colorectal Cancer
  • FOLFOX regimen
  • +3 more
  • Madrid, Spain
    Spanish Cooperative Group for the Treatment of Digestive Tumors
Mar 8, 2022

Metastatic Colorectal Cancer, KRAS Gene Mutation Trial in United States (Onvansertib, Bevacizumab, FOLFIRI)

Active, not recruiting
  • Metastatic Colorectal Cancer
  • KRAS Gene Mutation
  • Phoenix, Arizona
  • +6 more
Nov 10, 2022

Metastatic Colorectal Cancer Trial in Denmark, Germany, Spain (FOLFIRI Protocol, SCO-101)

Recruiting
  • Metastatic Colorectal Cancer
  • Aalborg, Denmark
  • +11 more
Feb 28, 2022

Metastatic Colorectal Cancer Trial in Kashiwa, Chiba, Nagoya, Aichi (BBI608, 5-FU, Irinotecan)

Completed
  • Metastatic Colorectal Cancer
  • Kashiwa, Chiba, Japan
  • +1 more
Apr 9, 2022

Neuroendocrine Tumor Trial in Beijing (PM8002, FOLFIRI)

Recruiting
  • Neuroendocrine Neoplasm
  • Beijing, China
    Chinese PLA General Hospital
May 25, 2023